Filtered By:
Condition: Schizophrenia
Drug: Insulin
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Beyond the brain: disrupted in schizophrenia 1 regulates pancreatic {beta}-cell function via glycogen synthase kinase-3{beta} Research Communication
Individuals with schizophrenia and their first-degree relatives have higher rates of type 2 diabetes (T2D) than the general population (18–30 vs. 1.2–6.3%), independent of body mass index and antipsychotic medication, suggesting shared genetic components may contribute to both diseases. The cause of this association remains unknown. Mutations in disrupted in schizophrenia 1 (DISC1) increase the risk of developing psychiatric disorders [logarithm (base 10) of odds = 7.1]. Here, we identified DISC1 as a major player controlling pancreatic β-cell proliferation and insulin secretion via regulation of glycogen ...
Source: FASEB Journal - February 1, 2016 Category: Biology Authors: Jurczyk, A., Nowosielska, A., Przewozniak, N., Aryee, K.-E., DiIorio, P., Blodgett, D., Yang, C., Campbell-Thompson, M., Atkinson, M., Shultz, L., Rittenhouse, A., Harlan, D., Greiner, D., Bortell, R. Tags: Research Communication Source Type: research
